Clinical Trial Update: Basiliximab for the Treatment of Acute Graft-versus-host Disease After Allogeneic Stem Cell Transplantation [NA]

View source ↗

Summary

A clinical trial update describing the use of Basiliximab for treating acute graft-versus-host disease after allogeneic stem cell transplantation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• Basiliximab (basiliximab)

Snippet

Sponsor: Hospital Authority, Hong Kong | Conditions: Graft vs Host Disease, Hematopoietic Stem Cell Transplantation | NA | Status: UNKNOWN